Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
4.080
-0.470 (-10.33%)
At close: Mar 9, 2026, 4:00 PM EDT
4.050
-0.030 (-0.74%)
After-hours: Mar 9, 2026, 8:00 PM EDT
Can-Fite BioPharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 6 | 16 | 9 | 19 | 39 | 29 | |
| Market Cap Growth | -60.82% | 75.98% | -54.62% | -49.45% | 34.30% | 121.59% | |
| Enterprise Value | -1 | 11 | 0 | 9 | 24 | 18 | |
| Last Close Price | 4.55 | 32.50 | 44.00 | 122.60 | 258.00 | 356.00 | |
| PS Ratio | 11.39 | 23.09 | 11.90 | 24.06 | 45.20 | 37.63 | |
| PB Ratio | 1.52 | 2.86 | 1.42 | 4.36 | 2.68 | 4.73 | |
| P/TBV Ratio | 1.52 | 2.86 | 1.42 | 4.36 | 2.68 | 4.73 | |
| EV/Sales Ratio | - | 15.92 | 0.65 | 10.63 | 28.70 | 23.35 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -1.52 | -1.43 | -1.42 | -1.77 | -1.32 | -1.36 | |
| Net Debt / EBITDA Ratio | 0.72 | 0.96 | 1.09 | 0.79 | 1.48 | 0.59 | |
| Net Debt / FCF Ratio | 0.76 | 1.02 | 1.05 | 0.73 | 1.93 | 0.69 | |
| Asset Turnover | 0.08 | 0.07 | 0.08 | 0.06 | 0.06 | 0.09 | |
| Quick Ratio | 3.05 | 3.84 | 4.42 | 3.19 | 7.01 | 6.57 | |
| Current Ratio | 3.60 | 4.38 | 4.91 | 3.66 | 7.35 | 7.41 | |
| Return on Equity (ROE) | -264.12% | -134.94% | -142.49% | -107.91% | -123.34% | -339.20% | |
| Return on Assets (ROA) | -81.86% | -53.18% | -53.15% | -42.73% | -53.91% | -99.87% | |
| Return on Capital Employed (ROCE) | -159.50% | -115.00% | -102.80% | -148.90% | -73.30% | -171.30% | |
| Earnings Yield | -137.95% | -50.64% | -86.33% | -52.20% | -32.72% | -50.31% | |
| FCF Yield | -130.99% | -49.11% | -95.47% | -55.47% | -25.60% | -42.11% | |
| Buyback Yield / Dilution | -87.11% | -70.22% | -56.71% | -47.49% | -54.32% | -317.20% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.